Inactivation of TP53 and RB1 appeared to be key requirements for the ex vivo propagation of neuroendocrine cells (21), and accordingly the genetic alterations of those genes are frequent in NEC. The gene discussed is TP53; the disease is neuroendocrine carcinoma.